NYSE · Medical - Instruments & Supplies

AVTR (AVTR) Stock

$13.36 -2.34% NYSE: AVTR Healthcare

Valuation

MetricValue
Price$13.36
Market Cap$9.04B
P/E Ratio-9.79
P/B Ratio0.94
P/S Ratio0.80
EPS (TTM)$-0.78
52-Week High$15.93
52-Week Low$7.26
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.52%
ROA-4.49%
ROCE-4.42%
Gross Margin-3.75%
Operating Margin-3.75%
Net Margin-8.42%
Debt/Equity0.01
Current Ratio1.78

Annual Financials (USD)

Metric20212022202320242025
Revenue$7.4B$7.5B$7.0B$6.8B$6.6B
Operating Profit$972.0M$1.1B$696.0M$1.1B$-246.0M
Net Profit$573.0M$687.0M$321.0M$712.0M$-530.0M
EPS$0.85$1.01$0.47$1.04$-0.78
Op Margin13.2%15.0%10.0%16.0%-3.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$13.9B$13.5B$13.0B$12.1B$11.8B
Total Liabilities$9.7B$8.6B$7.7B$6.2B$6.2B
Cash$302.0M$373.0M$263.0M$262.0M$365.0M
Borrowings$7.0B$6.3B$5.5B$4.1B$3.9B

Latest News

Will Avantor (AVTR) Beat Estimates Again in Its Next Earnings Report? Zacks · Jul 15, 2026 Avantor Stock Up on NuSil's Expanded HIV Prevention Partnership Zacks · Jul 15, 2026 AVTR: Raising target price to $12.00 Argus Research · Jul 15, 2026 Avantor's NuSil Brand Expands HIV Prevention Collaboration With Population Council MT Newswires · Jul 14, 2026 Avantor's® NuSil® Brand Expands Partnership with the Population Council to Develop Long-Acting HIV Prevention Product PR Newswire · Jul 14, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$954.0M$844.0M$870.0M$841.0M$624.0M
Investing Cash Flow$-4.2B$-243.0M$-290.0M$290.0M$-259.0M
Financing Cash Flow$16.0M$4.0M$2.0M$61.0M$-96.0M
Net Cash Flow$38.0M$70.0M$-109.0M$-23.0M$104.0M
Free Cash Flow$843.0M$710.0M$724.0M$692.0M$495.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA53.64
FCF Yield8.41%
Quick Ratio1.17
Interest Coverage-1.45
Return 1Y-10.94%
Return 3Y-52.22%
Return 5Y-70.38%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATR $136.77 +2.10% 19.32 $8.73B 1.66%
BAXBaxter International Inc. $23.18 +3.46% 11.25 $11.97B 0.88%
BIO $330.54 +4.47% 10.29 $8.94B 0.00%
GRFSGrifols, S.A. $7.27 -0.27% 14.60 $6.15B 1.24%
HSIC $86.51 +0.89% 22.31 $9.85B 0.00%

About AVTR

AVTR is led by CEO Emmanuel Ligner, employs 13,500 people, headquartered in Radnor, US, publicly traded since 2019.

AVTR stock trades at $13.36 with a market capitalization of $9.04B. The stock is valued at a price-to-earnings (P/E) ratio of -9.79, price-to-book of 0.94, price-to-sales of 0.80. Over the past 52 weeks the stock has ranged between $7.26 and $15.93, and currently trades 16.1% below its 52-week high.

On profitability, AVTR generates a return on equity (ROE) of -9.52%, return on capital employed of -4.42%, an operating margin of -3.75%, a net profit margin of -8.42%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides